Patents by Inventor Ismael Samudio

Ismael Samudio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-podocalyxin antibodies and methods of using the same
    Patent number: 12053524
    Abstract: The present invention is directed to anti-podocalyxin antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of cancer.
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: August 6, 2024
    Inventors: Kelley Marshall McNagny, Calvin D. Roskelley, Michael R. Hughes, Diana Canals Hernaez, Klas Ola Blixt, John Stephen Babcook, Christopher John Bond, Ismael Samudio, Jan Peter Bergqvist, Katherine Grace MacDonald, Anna Von Rossum, Bradley John Hedberg, Pamela Megan Dean
  • ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME
    Publication number: 20220288203
    Abstract: The present invention is directed to anti-podocalyxin antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of cancer.
    Type: Application
    Filed: August 13, 2021
    Publication date: September 15, 2022
    Inventors: Kelley Marshall MCNAGNY, Calvin D. ROSKELLEY, Michael R. HUGHES, Diana CANALS HERNAEZ, Klas Ola BLIXT, John Stephen BABCOOK, Christopher John BOND, Ismael SAMUDIO, Jan Peter BERGQVIST, Katherine Grace MACDONALD, Anna VON ROSSUM, Bradley John HEDBERG, Pamela Megan DEAN
  • GENETICALLY MODIFIED ENTEROVIRUS VECTORS
    Publication number: 20220267799
    Abstract: A replicating oncolytic virus vector is provided having a modified Enterovirus genome (e.g., a Poliovirus, Coxsackievirus or Echovirus genome), wherein the modified Enterovirus genome has one or more copies of one or more miRNA target sequences operably linked to an untranslated region (UTR) of the Enterovirus genome. Also provided are compositions and methods for treating cancer (including for example, lung cancer).
    Type: Application
    Filed: August 5, 2020
    Publication date: August 25, 2022
    Inventors: Honglin Luo, William Wei-Guo Jia, Huitao Liu, Ismael Samudio
  • CHELATORS AND METHODS OF MAKING AND USING SAME
    Publication number: 20220160908
    Abstract: A chelating agent having the general formula (I) is provided (I) Metal chelates and constructs for carrying out targeted radionuclide therapy incorporating such chelating agents are provided. Methods of making and using the chelating agent, metal chelates and constructs for carrying out targeted radionuclide therapy, as well as diagnostic and therapeutic methods using such constructs, are provided.
    Type: Application
    Filed: September 25, 2019
    Publication date: May 26, 2022
    Inventors: Lee Lee Lily LI, Chris ORVIG, Francois BENARD, Kuo-Shyan LIN, Julie Marie ROUSSEAU, Ismael SAMUDIO
  • Anti-podocalyxin antibodies and methods of using the same
    Patent number: 11090383
    Abstract: The present invention is directed to anti-podocalyxin antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of cancer.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: August 17, 2021
    Inventors: Kelly Marshall McNagny, Calvin D. Roskelley, Michael R. Hughes, Diana Canals Hernaez, Klas Ola Blixt, John Stephen Babcook, Christopher John Bond, Ismael Samudio, Jan Peter Bergqvist, Katherine Grace MacDonald, Anna Von Rossum, Bradley John Hedberg, Pamela Megan Dean
  • ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME
    Publication number: 20180296673
    Abstract: The present invention is directed to anti-podocalyxin antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of cancer.
    Type: Application
    Filed: September 30, 2016
    Publication date: October 18, 2018
    Inventors: Kelly Marshall MCNAGNY, Calvin D. ROSKELLEY, Michael R. HUGHES, Diana Canals HERNAEZ, Klas Ola BLIXT, John Stephen BABCOOK, Christopher John BOND, Ismael SAMUDIO, Jan Peter BERGQVIST, Katherine Grace MACDONALD, Anna VON ROSSUM, Bradley John HEDBERG
  • Inhibition of atherosclerosis by diindolylmethane analogs
    Publication number: 20060079568
    Abstract: Diindolylmethane analogs such as 1,1-bis(3?-indolyl)-1-(p-substituted phenyl)methanes can be used to treat atherosclerosis and other vascular disease states. The analogs have been shown to display antiinflammatory effects in endothelial cells, suggesting their clinical applicability.
    Type: Application
    Filed: May 20, 2005
    Publication date: April 13, 2006
    Applicant: The Texas A&M University System
    Inventors: Stephen Safe, Ismael Samudio, Paolo Calabro, Edward Yeh